Peeling-back-blister-with-zoom-of-triangle (Image 01)
Kloxxado Spray
Product Images NDC 59467-679
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Kloxxado (NDC 59467-679). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Specialty Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1(a)-naloxone-hcl-ns-8mg-with-stand-dev (Image 02)
This is a graph that shows the mean concentration of Naloxone in plasma in ng/mL at different time intervals for different routes of administration. The routes of administration tested were nasal spray, intravenous injection, and intramuscular injection. The concentration is highest for intravenous injection and lowest for intramuscular injection. The graph is a comparison of studies I, I1, and II.*
Figure-1(b)-naloxone-hcl-ns-8mg-with-stand-dev (Image 03)
The text represents a graphical table showing the mean concentration of Naloxone in plasma (ng/ml) over time (hr) for different administration methods in different studies. The adminstration methods are Nasal Spray 8 mg, Intravenous Injection 2 mg, and Intramuscular Injection 0.4 mg. The range of Naloxone concentration is from 0.05 to 35 ng/ml, and the time range is from 0.5 to 1 hr.*
Kloxxado-fc-c50001063-02-k03 (Image 04)
Ifu-image-2-proper-way-to-hold-device (Image 05)
Ifu-image-3-support-back-of-neck (Image 06)
Ifu-image-4-insert-tip-into-nostril (Image 07)
Ifu-image-5-place-patient-on-their-side (Image 08)
Ifu-image-6-clock-2-3-minutes (Image 09)
Kloxxado is a nasal spray indicated for the treatment of known or suspected opioid overdose. It should not be removed until ready for use and device testing before use is not recommended. The product comes in a pack of two and its expiration date should be checked before use. Each nasal spray contains 8 mg of medication.*
Image 10
NDC 59467-679-01 is a prescription nasal spray called QR Kloxxad 0. It contains 8mg of naloxone HC per unit dose spray and is intended for use in the nose only. It is to be used for known or suspected opioid overdose but should not be used above 40°C (104°F) or after freezing. The device should not be tested before use and quick instructions are included.*
Image 11
Image 12
Image-chemical-structure-usp.jpg (Image Chemical Structure Usp)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
